Abstract

Noncoding RNAs are emerging as potent and multifunctional regulators in all biological processes. In parallel, a rapidly growing number of studies has unravelled associations between aberrant noncoding RNA expression and human diseases. These associations have been extensively reviewed, often with the focus on a particular microRNA (miRNA) (family) or a selected disease/pathology. In this Mini‐Review, we highlight a selection of studies in order to demonstrate the wide‐scale involvement of miRNAs and long noncoding RNAs in the pathophysiology of three types of diseases: cancer, cardiovascular and neurological disorders. This research is opening new avenues to novel therapeutic approaches.

Highlights

  • Noncoding RNAs are emerging as potent and multifunctional regulators in all biological processes

  • myocardial infarction–associated transcript (MIAT) is found at low levels in platelets from patients with myocardial infarction [147], whereas elevated levels of this Long noncoding RNAs (lncRNAs) are found in myocardial samples from patients with dilated cardiomyopathy suffering from Chagas disease [148]

  • The constellations of physiological processes which orchestrate life are subject to intricate control

Read more

Summary

Evangelia Lekka and Jonathan Hall

Noncoding RNAs are emerging as potent and multifunctional regulators in all biological processes. A rapidly growing number of studies has unravelled associations between aberrant noncoding RNA expression and human diseases. These associations have been extensively reviewed, often with the focus on a particular microRNA (miRNA) (family) or a selected disease/ pathology. In this Mini-Review, we highlight a selection of studies in order to demonstrate the wide-scale involvement of miRNAs and long noncoding RNAs in the pathophysiology of three types of diseases: cancer, cardiovascular and neurological disorders.

Edited by Wilhelm Just
Translational repression mRNA deadenylation mRNA cleavage
MiRNAs and long noncoding RNAs in cancer
MiRNAs and long noncoding RNAs in cardiovascular disease
MiRNAs and long noncoding RNAs in neurodegenerative disease
Findings
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.